Corona del Mar, California (PRWEB) December 20, 2011
Integrated Oncology Network, LLC (“ION”). ION and its related entities SightLine Health, LLC (“SightLine”), Vicura Oncology, LLC (“Vicura”) and Prologics, LLC (“Prologics”) announced today that Nicki McKnight has joined the company as its Director of Compliance. Ms. McKnight will oversee all compliance programs at SightLine, Vicura, Prologics and all future ION partners. Ms. McKnight assisted with the development and managed the compliance programs at both OnCure Medical Corp. and most recently Vantage Oncology. Ms. McKnight brings with her a decade of expertise as a certified coder in radiation oncology as well as working with some of the top tier healthcare law firms in the United States implementing compliance programs, policies and procedures.
“The appointment of Nicki, with whom I worked closely while at OnCure, is an example of our collective organization’s dedication to assure proper adherence to our compliance programs, policies and procedures.” said Jeffrey Goffman, the chairman and CEO of ION.
TJ Farnsworth, SightLine’s chief executive officer, said, “SightLine is excited to work with Nicki to ensure all of our centers continue to abide by the strictest levels of compliance. Our entire management team and physician partners recognize the tremendous value that Nicki brings to our organization.”
“Nicki has worked with some of the top companies and physicians in the radiation oncology sector, and we look forward to working with her and benefiting from her expertise” said Mark Cherney, the chief executive officer of Prologics.
ION, headquartered in Corona del Mar, California, is a radiation oncology management and development company that provides oncology solutions and capital for physician practices and hospitals who seek strategic, financial, and management expertise. ION’s management team has expertise in assisting physicians with the formation of integrated oncology groups, which can enhance operational efficiencies and optimize utilization while continuing to focus on providing the best patient care. ION provides solutions for project development for cancer centers, financing, and management services with expertise in radiation oncology operations, billing and collection, accounting, compliance, IT, M&A, physics and dosimetry, and other administrative services. ION provides liquidity for physician and hospital owners as it invests as a minority partner in radiation oncology centers with both physicians and hospitals. ION’s management team has over 50 years of combined health care expertise, including working with several of the most prestigious oncology groups in the country as a trusted
resource. Currently, ION is a partner in twelve (12) radiation centers, is a partner with HCA and has an exclusive alliance with Philips. For more information on ION, please visit our web site at http://www.ion-llc.com
ION is a privately held company whose shareholders include a small group of strategic investors, including Capricorn Investment Group and Comvest Group.
About SightLine Health, LLC
SightLine Health, headquartered in Houston, Texas, specializes in groundbreaking cancer treatments such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), high-dose-rate (HDR) brachytherapy, and electron-beam radiation therapy. The company opened its first facility near the renowned Texas Medical Center, in 2005 and was recently ranked 86 on Inc. magazine’s 2011 Inc. 500 list. For more information on SightLine Health or any of its effective treatments, please visit http://www.sightlinehealth.com.
About Prologics, LLC and Northern Ohio Regional Cancer Center
Prologics is located in Franklin, Tenn., and was founded in 2005 by professionals with many years of expertise with physician practice management, urological care, radiation oncology management services experience. The original founders comprised of physicians and experienced healthcare executives. The company has grown and is currently providing services in Ohio, Maryland, Pennsylvania, North Dakota, and Texas. For more information visit http://www.prologics.net
The Northern Ohio Regional Cancer Center has been operational since late 2007 and currently provides radiation therapy services on behalf of multiple physician groups in Northwest Ohio. NORCC operates two linear accelerators with state of the art IGRT technology. For more information visit http://www.norcc1.com
About Vicura Oncology LLC
Vicura is located in Long Beach, California, and through its subsidiaries owns four radiation oncology centers in Southern California, as well as a medical physics company and a medical radiation oncology billing company. In addition, the physician partners of Vicura provide professional radiation oncology medical services at four hospital based cancer centers in Southern California. Vicura through its predecessor entities has owned and operated radiation oncology centers in the Southern California region for over twenty years.
About Capricorn Investment Group
Capricorn Investment Group is a private, independent investment firm designed to be an ideal partner for clients desiring a global portfolio driven by consistent returns and underpinned by a principled philosophy. Capricorn currently manages approximately $5 billion through various investment strategies, which cover a range of areas, from long term, diversified global growth investment strategies, venture capital and private equity, credit strategies, and “clean and green” growth capital. Capricorn’s investment philosophy is grounded in a strong fundamentals focused investment model, comprehensive research on long term, global mega-themes, such as energy, agriculture, transportation, consumer, health and wellness, technology, and consideration of business smart sustainability principles.
About Comvest Group
The Comvest Group is a leading private investment firm focused on providing debt and equity capital to lower middle-market companies. Our firm includes seasoned, senior level operating executives at all levels who partner with managers and owners of companies to grow businesses and create long-term value. Since 1988, Comvest has invested more than $2 billion of capital in over 200 public and private companies. For more information, please visit http://www.comvest.com.
Statements in this Press Release that are not historical facts constitute “forward-looking statements.” Any statements contained herein which are not historical facts or which contain the words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “should,” and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION’s industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.